Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 40, 3591-3597, October 1, 1980]
© 1980 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Von Hoff, D. D.
Right arrow Articles by Altman, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Von Hoff, D. D.
Right arrow Articles by Altman, A.

Direct Cloning of Human Neuroblastoma Cells in Soft Agar Culture1

Daniel D. Von Hoff2, James Casper, Edward Bradley, Jeff M. Trent, Albertina Hodach, Cheryl Reichert, Robert Makuch and Arnold Altman

Department of Medicine, Division of Oncology, University of Texas Health Science Center, at San Antonio, San Antonio, Texas 78284 [D. D. Von H.]; Midwest Children's Cancer Center, Department of Pediatrics, Medical College of Wisconsin, Milwaukee Children's Hospital and The Blood Center of Southeastern Wisconsin, Milwaukee, Wisconsin 53233 [J. C., A. H.]; Medicine Branch [E. B.], Department of Pathology [C. R.], and Clinical Oncology Program, Division of Cancer Treatment [R. M.], National Cancer Institute, Bethesda, Maryland 20205; Department of Medicine, Section of Hematology/Oncology, Arizona Health Science Center, Tucson, Arizona 85724 [J. M. T.]; and Department of Pediatric Oncology, University of Connecticut, Farmingham, Connecticut 06032 [A. A.]

An in vitro soft agar technique was used in an attempt to culture neuroblastoma cells from 71 bone marrow, 3 lymph node, and 2 solid tumor specimens from 18 patients with neuroblastoma. One-half of each specimen was sent for routine pathology studies and one-half was cultured in the soft agar system. Colonies appeared within 10 days in histologically positive bone marrows. Light microscopy, electron microscopy, catecholamine secretion, and karyology provided evidence that the colonies were composed of neuroblastoma cells. There were 38 instances in which histological study of the specimen demonstrated neuroblastoma cells. The soft agar system showed colony growth in 30 of these samples (79%). There were a total of 38 specimens that were histologically negative for neuroblastoma. Thirty of these 38 specimens showed no growth in the stem cell assay. Eight histologically negative specimens from 6 patients formed colonies in the soft agar system. Five of these 6 patients showed tumor histologically on prior or subsequent marrow examinations. In addition to a significant correlation between histological and soft agar culture results (p < 0.001), there exists a highly significant positive correlation between the number of colonies per plate and the histological status of the specimen (p < 0.005). Serial marrow samples were cultured on 7 patients. There appears to be an association between the number of colonies that develop in the plate and the clinical course and prognosis of the patient. Decreasing plating efficiencies (number of colonies per number of cells plated) correlated with tumor response. Increasing plating efficiencies indicated tumor relapse. A plating efficiency of ≥0.1% portended a particularly poor prognosis. Neuroblastoma grows well in this soft agar culture system. This excellent growth provides a good model for both clinical and basic science studies of neuroblastoma.

1 Supported in part by American Cancer Society Research Grant CH162; BRSG Grant 507 BR-05654 awarded by Biomedical Research Support Grant Program, Division of Research Resources, NIH; American Cancer Society Institutional Grant IN-116B; National Cancer Institute Research Grant CA26226; and the MACC fund (Midwest Athletics Against Childhood Cancer).

2 To whom requests for reprints should be addressed.

Received 1/21/80. Accepted 7/14/80.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1980 by the American Association for Cancer Research.